Adalimumab and methotrexate combination could improve disease control for early-stage rheumatoid arthritis patients

被引：0
|
作者：
不详
机构：
来源：
EXPERT REVIEW OF CLINICAL IMMUNOLOGY | 2011年 / 7卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：408 / 408
页数：1
相关论文
共 50 条
  • [1] Adalimumab and methotrexate combination could improve disease control for early-stage rheumatoid arthritis patients
    不详
    IMMUNOTHERAPY, 2011, 3 (08) : 924 - 924
  • [2] Is adalimumab in combination with methotrexate a safe and efficacious treatment for early rheumatoid arthritis?
    Josef S Smolen
    Daniel Aletaha
    Nature Clinical Practice Rheumatology, 2006, 2 (5): : 242 - 243
  • [3] DISEASE FLARES AMONG EARLY RHEUMATOID ARTHRITIS PATIENTS TREATED WITH CONTINUED METHOTREXATE EITHER ALONE OR IN COMBINATION WITH ADALIMUMAB
    Kavanaugh, A.
    van Vollenhoven, R.
    Sunkureddi, P.
    Zhang, Y.
    Suboticki, J.
    Smolen, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 1371 - 1372
  • [4] Disease Flares Among Early Rheumatoid Arthritis Patients Treated with Continued Methotrexate Either Alone or in Combination with Adalimumab (Humira)
    Kavanaugh, Arthur
    van Vollenhoven, Ronald F.
    Sunkureddi, Prashanth
    Zhang, Ying
    Suboticki, Jessica L.
    Smolen, Josef S.
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [5] DISEASE FLARES AMONG EARLY RHEUMATOID ARTHRITIS PATIENTS TREATED WITH CONTINUED METHOTREXATE EITHER ALONE OR IN COMBINATION WITH ADALIMUMAB (HUMIRA)
    Kavanaugh, A.
    van Vollenhoven, R. F.
    Sunkureddi, P.
    Zhang, Y.
    Suboticki, J. L.
    Smolen, J. S.
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2018, 24 : S75 - S76
  • [6] Treating Rheumatoid Arthritis to Target: Outcomes and Predictors in Early Rheumatoid Arthritis Patients Treated with Adalimumab Plus Methotrexate, Methotrexate Alone, or Methotrexate Plus Subsequent Adalimumab
    Smolen, Josef
    Fleischmann, Roy M.
    Emery, Paul
    van Vollenhoven, Ronald F.
    Guerette, Benoit
    Santra, Sourav
    Kupper, Hartmut
    Redden, Laura
    Wolfe, Benjamin
    Kavanaugh, Arthur
    ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S665 - S665
  • [7] TREATING RHEUMATOID ARTHRITIS TO TARGET: OUTCOMES AND PREDICTORS IN EARLY RHEUMATOID ARTHRITIS PATIENTS TREATED WITH ADALIMUMAB PLUS METHOTREXATE, METHOTREXATE ALONE OR METHOTREXATE PLUS SUBSEQUENT ADALIMUMAB
    Smolen, Josef S.
    Fleischmann, Roy M.
    Emery, Paul
    van Vollenhoven, Ronald F.
    Guerette, Benoit
    Santra, Sourav
    Kupper, Hartmut
    Redden, Laura
    Kavanaugh, Arthur
    RHEUMATOLOGY, 2012, 51 : 114 - 115
  • [8] ACHIEVING LONG-TERM COMPREHENSIVE DISEASE CONTROL WITH ADALIMUMAB AND METHOTREXATE IN PATIENTS WITH EARLY RHEUMATOID ARTHRITIS IN THE OPTIMA STUDY
    Emery, P.
    Smolen, J. S.
    Fleischmann, R.
    van Vollenhoven, R.
    Florentinus, S.
    Santra, S.
    Kupper, H.
    Redden, L.
    Kavanaugh, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 369 - 370
  • [9] The combination glucocorticoid-adalimumab-methotrexate as induction therapy in early aggressive rheumatoid arthritis
    Montecucco, Carlomaurizio
    Caporali, Roberto
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2013, 31 (05) : 829 - 829
  • [10] Achieving Comprehensive Disease Control in Long-Standing or Early Rheumatoid Arthritis Patients Treated with Adalimumab Plus Methotrexate versus Methotrexate Alone
    Keystone, Edward
    Breedveld, Ferdinand
    Van der Heijde, Desiree
    Van Vollenhoven, Ronald
    Florentinus, Stefan
    Faccin, Freddy
    Liu, Shufang
    Kupper, Hartmut
    Kavanaugh, Arthur
    JOURNAL OF RHEUMATOLOGY, 2013, 40 (06) : 996 - 996
12345